OCLN and Cerebral ischemia: Based on occludin protein as a potential biomarker for cerebral ischemia‐induced BBB injury and BBB disruption after ICH onset being engaged in PHE development, we further focused on ICH patients to determine whether the baseline level of occludin was associated with the severity of the PHE.